Pay in 4 interest-free payments of $6.69 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
The compound was developed by the Australian biotech firm Metabolic Pharmaceuticals as a research tool to isolate the lipolytic signaling domain of growth hormone without the receptor-binding region responsible for its anabolic and glucose-handling effects
This particular function of BPC-157 may make it possible to develop an effective oral treatment for slow-growing arterial occlusions, such as are seen in atherosclerotic heart disease
Not using full protocol Mistake : Stopping after 1-2 weeks when feeling better
Product Overview
US$ 26.35
US$ 23.03
US$ 24.78
US$ 20.08
US$ 25.74
